Assessment of HER2 Status in Breast Cancer: Overall Positivity Rate and Accuracy by Fluorescence in Situ Hybridization and Immunohistochemistry in a Single Institution Over 12 Years: A Quality Control Study
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-615
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Springer Science and Business Media LLC